• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠肽转运体PEPT1和PEPT2对L-氨基酸酯化合物的识别。

Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2.

作者信息

Sawada K, Terada T, Saito H, Hashimoto Y, Inui K I

机构信息

Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Kyoto, Japan.

出版信息

J Pharmacol Exp Ther. 1999 Nov;291(2):705-9.

PMID:10525090
Abstract

Peptide transporters (PEPT1 and PEPT2) in epithelia play an important role in the absorption of small peptides and peptide-like drugs. Recently, it was demonstrated that various nonpeptidic compounds can be transported by these transporters. In the present study, we focused on the L-amino acid ester compounds and examined the mechanisms of their interaction with rat PEPTs (rPEPTs) using stable transfectants. Valacyclovir, the L-valyl ester prodrug of the antiherpetic agent acyclovir, competitively inhibited [(14)C]glycylsarcosine uptake in the rPEPT1- or rPEPT2-expressing cells. Dixon plot analyses showed that the inhibition constant (K(i)) values of valacyclovir were 2.7 and 0.22 mM for rPEPT1 and rPEPT2, respectively, suggesting that rPEPT2 had higher affinity for this agent. Various L-valine alkyl esters significantly inhibited [(14)C]glycylsarcosine uptake. L-Valine methyl ester (Val-OMe) competitively inhibited [(14)C]glycylsarcosine uptake with K(i) values of 3.6 and 0.83 mM for rPEPT1 and rPEPT2, respectively, indicating that Val-OMe is also a high-affinity substrate for rPEPT2. Val-OMe had a trans-stimulation effect on [(14)C]glycylsarcosine efflux from both transfectants, suggesting the translocation of L-valine methyl ester via rPEPTs. Val-OMe showed the most potent inhibitory effect among the several L-amino acid methyl esters examined. We conclude that Val-OMe, as well as valacyclovir, could be recognized and transported by rPEPT1 and rPEPT2 and that these L-valyl esters showed higher affinity for rPEPT2 as do most substrates of these transporters. Our results suggest that L-valine is a desirable L-amino acid for the esterification of poorly permeable drugs to enhance their oral bioavailability targeting intestinal PEPT1.

摘要

上皮细胞中的肽转运体(PEPT1和PEPT2)在小肽和类肽药物的吸收中发挥着重要作用。最近,已证明这些转运体可转运各种非肽类化合物。在本研究中,我们聚焦于L-氨基酸酯化合物,并使用稳定转染细胞研究了它们与大鼠肽转运体(rPEPTs)相互作用的机制。伐昔洛韦是抗疱疹药阿昔洛韦的L-缬氨酰酯前药,竞争性抑制表达rPEPT1或rPEPT2的细胞对[¹⁴C]甘氨酰肌氨酸的摄取。Dixon作图分析表明,伐昔洛韦对rPEPT1和rPEPT2的抑制常数(Kᵢ)值分别为2.7和0.22 mM,这表明rPEPT2对该药物具有更高的亲和力。各种L-缬氨酸烷基酯均显著抑制[¹⁴C]甘氨酰肌氨酸的摄取。L-缬氨酸甲酯(Val-OMe)竞争性抑制[¹⁴C]甘氨酰肌氨酸的摄取,对rPEPT1和rPEPT2的Kᵢ值分别为3.6和0.83 mM,表明Val-OMe也是rPEPT2的高亲和力底物。Val-OMe对两种转染细胞中[¹⁴C]甘氨酰肌氨酸的外排均有反式刺激作用,提示L-缬氨酸甲酯通过rPEPTs进行转运。在所检测的几种L-氨基酸甲酯中,Val-OMe显示出最有效的抑制作用。我们得出结论,Val-OMe与伐昔洛韦一样,可被rPEPT1和rPEPT2识别并转运,并且这些L-缬氨酰酯对rPEPT2显示出更高的亲和力,就像这些转运体的大多数底物一样。我们的结果表明,L-缬氨酸是用于对渗透性差的药物进行酯化以提高其靶向肠道PEPT1的口服生物利用度的理想L-氨基酸。

相似文献

1
Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2.大鼠肽转运体PEPT1和PEPT2对L-氨基酸酯化合物的识别。
J Pharmacol Exp Ther. 1999 Nov;291(2):705-9.
2
Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.伐昔洛韦:肠道和肾脏肽转运体PEPT1和PEPT2的底物。
Biochem Biophys Res Commun. 1998 May 19;246(2):470-5. doi: 10.1006/bbrc.1998.8628.
3
Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.阿昔洛韦二肽酯前药与肠道寡肽转运体的相互作用:对人肠上皮细胞系Caco-2中甘氨酰肌氨酸转运的竞争性抑制
J Pharmacol Exp Ther. 2003 Feb;304(2):781-91. doi: 10.1124/jpet.102.044313.
4
Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.在过表达人肽转运体的Caco-2/hPEPT1细胞中氨基酸酯前药的细胞摄取机制
Pharm Res. 1998 Sep;15(9):1382-6. doi: 10.1023/a:1011945420235.
5
Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism.阿昔洛韦新型二肽酯前药口服给药后的药代动力学:肠道吸收与肝脏代谢。
J Pharmacol Exp Ther. 2004 Nov;311(2):659-67. doi: 10.1124/jpet.104.069997. Epub 2004 Jun 29.
6
Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2.确定肽转运体PEPT1和PEPT2底物亲和力的结构要求。
Pflugers Arch. 2000 Sep;440(5):679-84. doi: 10.1007/s004240000339.
7
Characterization of stably transfected kidney epithelial cell line expressing rat H+/peptide cotransporter PEPT1: localization of PEPT1 and transport of beta-lactam antibiotics.表达大鼠H⁺/肽共转运体PEPT1的稳定转染肾上皮细胞系的特性:PEPT1的定位及β-内酰胺类抗生素的转运
J Pharmacol Exp Ther. 1997 Jun;281(3):1415-21.
8
Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells.Caco-2细胞基底外侧肽转运体对非肽类化合物的识别及转运特性
J Pharmacol Exp Ther. 2001 Aug;298(2):711-7.
9
Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.双功能肽模拟物前药提高了去羟肌苷的肠道通透性和增强酸性稳定性:合成、跨上皮转运、化学稳定性和药代动力学。
Mol Pharm. 2011 Apr 4;8(2):319-29. doi: 10.1021/mp100376q. Epub 2011 Mar 4.
10
Effects of glibenclamide on glycylsarcosine transport by the rat peptide transporters PEPT1 and PEPT2.格列本脲对大鼠肽转运体PEPT1和PEPT2转运甘氨酰肌氨酸的影响。
Br J Pharmacol. 1999 Nov;128(6):1159-64. doi: 10.1038/sj.bjp.0702895.

引用本文的文献

1
Acetylation turns leucine into a drug by membrane transporter switching.乙酰化作用通过膜转运蛋白转换将亮氨酸变成药物。
Sci Rep. 2021 Aug 4;11(1):15812. doi: 10.1038/s41598-021-95255-5.
2
Recent advances in understanding prodrug transport through the SLC15 family of proton-coupled transporters.质子偶联转运体 SLC15 家族对前药转运的研究进展。
Biochem Soc Trans. 2020 Apr 29;48(2):337-346. doi: 10.1042/BST20180302.
3
Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles.肠和肝的药物转运体:药代动力学、病理生理学和药物遗传学作用。
J Gastroenterol. 2015 May;50(5):508-19. doi: 10.1007/s00535-015-1061-4. Epub 2015 Mar 14.
4
Evolution of an amino acid based prodrug approach: stay tuned.基于氨基酸的前药方法的演变:敬请期待。
Mol Pharm. 2013 Feb 4;10(2):445-58. doi: 10.1021/mp300663j. Epub 2013 Jan 22.
5
Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism.氟尿苷氨基酸酯前药:增强Caco-2细胞通透性及对糖苷键代谢的抗性
Pharm Res. 2005 Sep;22(9):1510-8. doi: 10.1007/s11095-005-6156-9. Epub 2005 Aug 24.
6
Computational modelling of H+-coupled peptide transport via human PEPT1.通过人肽转运体1(PEPT1)进行的H⁺偶联肽转运的计算模型
J Physiol. 2005 Jun 1;565(Pt 2):429-39. doi: 10.1113/jphysiol.2005.084582. Epub 2005 Mar 31.
7
Transport of amino acid esters and the amino-acid-based prodrug valganciclovir by the amino acid transporter ATB(0,+).氨基酸转运体ATB(0,+)对氨基酸酯和氨基酸类前体药物缬更昔洛韦的转运
Pharm Res. 2004 Jul;21(7):1303-10. doi: 10.1023/b:pham.0000033019.49737.28.
8
Theoretical predictions of drug absorption in drug discovery and development.药物发现与开发中药物吸收的理论预测。
Clin Pharmacokinet. 2002;41(11):877-99. doi: 10.2165/00003088-200241110-00005.